Dual regulation of FZD1/7 by IGF2BP3 enhances stem-like properties and carboplatin resistance in triple-negative breast cancer
Cancer Letters · 2025
DOI: 10.1016/j.canlet.2025.217944 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2025. Verfasst von Meng-Yuan Cai und 9 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Breast Disease Center & Department of General Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, 210029, China. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, RNA-Binding Proteins, Carboplatin, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Jiangsu Cancer Hospital, National Natural Science Foundation of China, Graduate Research and Innovation Projects of Jiangsu Province.
Abstract (Originalsprache)
Triple-negative breast cancer (TNBC) progression is driven by cancer stem cells (CSCs), contributing to chemoresistance and tumor recurrence. N6-methyladenosine (m6A) modification plays a critical role in regulating CSC plasticity; however, the key m6A regulators in TNBC-CSCs remain poorly defined. Here, we identified IGF2BP3 as a dominant m6A reader enriched in TNBC-CSCs through transcriptomic analysis of the TCGA-BRCA dataset and validation by fluorescence-activated cell sorting (FACS). Functional assays demonstrated that IGF2BP3 knockdown markedly impaired stem-like properties and sensitized CSCs to carboplatin. Mechanistically, IGF2BP3 directly bound to the 3'-untranslated regions of frizzled class receptor 1 and 7 (FZD1/7) mRNAs in an m6A-dependent manner, stabilizing their transcripts and promoting heterodimerization. This interaction activated the β-catenin pathway by facilitating nuclear translocation of non-phosphorylated β-catenin (Ser37/Thr41). RBM15 contributed to the m6A methylation of FZD1/7, enhancing IGF2BP3 recognition. Notably, Fz7-21, a small-molecule inhibitor of FZD1/7, phenocopied the effects of IGF2BP3 knockdown, disrupting CSC maintenance and homologous recombination repair (HRR). Moreover, Fz7-21 synergized with carboplatin to enhance its therapeutic efficacy in TNBC-CSCs. These findings establish IGF2BP3 as a central m6A reader that promotes stemness and carboplatin resistance via FZD1/7 stabilization and β-catenin signaling activation. Targeting IGF2BP3 and FZD1/7 have therapeutic potential to eliminate cancer stem cells and reduce carboplatin dosage in TNBC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangsu Breast Disease Center & Department of General Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, 210029, China.
- Department of Pharmacy, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 211166, China. Electronic address: weijifu@njmu.edu.cn.
- Jiangsu Breast Disease Center & Department of General Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, 210029, China. Electronic address: dingqiang@njmu.edu.cn.
Förderung
- Jiangsu Cancer Hospital
- National Natural Science Foundation of China
- Graduate Research and Innovation Projects of Jiangsu Province
- Science and Technology Support Program of Jiangsu Province
Zitieren
APA
Cai, M. Y., Yin, P., Wang, Z. W., Huang, Y. Z., Wang, Y. X., Wu, K. F., Zhang, X., Shi, L., Wei, J. F., & Ding, Q. (2025). Dual regulation of FZD1/7 by IGF2BP3 enhances stem-like properties and carboplatin resistance in triple-negative breast cancer. Cancer Letters. https://doi.org/10.1016/j.canlet.2025.217944
Vancouver
Cai MY, Yin P, Wang ZW, Huang YZ, Wang YX, Wu KF, et al. Dual regulation of FZD1/7 by IGF2BP3 enhances stem-like properties and carboplatin resistance in triple-negative breast cancer. Cancer Letters. 2025. doi:10.1016/j.canlet.2025.217944
BibTeX
@article{Cai2025,
author = {Cai, Meng-Yuan and Yin, Peng and Wang, Zi-Wen and Huang, Yu-Zhou and Wang, Yu-Xin and Wu, Kei-Fei and Zhang, Xu and Shi, Liang and Wei, Ji-Fu and Ding, Qiang},
title = {Dual regulation of FZD1/7 by IGF2BP3 enhances stem-like properties and carboplatin resistance in triple-negative breast cancer},
journal = {Cancer Letters},
year = {2025},
doi = {10.1016/j.canlet.2025.217944}
}
EUVIMED